Skip to main content
    S

    SurModics Inc (SRDX)

    Official site

    MEDICAL DEVICES

    $42.98
    +0.00 (+0.00%)

    Last updated: Nov 19, 2025 at 4:00 PM ET

    SurModics Inc (SRDX) Financials: Revenue, Profit and Cash Flow

    Updated Aug 8, 2025. Financial statements from company filings, amounts in US dollars.

    SurModics reported revenue of $126.08M for the fiscal year ended Sep 30, 2024, down 4.9% from the year before. That year, net income was -$11.54M with a net margin of -9.2%, operating cash flow was $248.00K and free cash flow was -$3.24M. The quarter ended Jun 30, 2025 had revenue of $29.57M and net income of -$5.32M.

    Revenue and Margins

    The operating margin was -4.5% in the fiscal year ended Sep 2024. Over the 9 years to Sep 2024, revenue grew from $61.90M, a compound annual rate of 8.2%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Sep 2024$126.08M-4.9%73.8%-4.5%-9.2%
    Sep 2023$132.58M+32.6%81.2%3.9%-1.2%
    Sep 2022$99.95M-4.9%79.6%-22.1%-27.3%
    Sep 2021$105.14M+10.8%83.7%6.4%4.0%
    Sep 2020$94.86M-5.2%83.9%-1.3%1.2%
    Sep 2019$100.08M+23.0%86.4%6.5%7.6%
    Sep 2018$81.34M+11.2%82.8%-10.8%-5.5%
    Sep 2017$73.11M+91.6%84.4%9.7%5.4%
    Sep 2016$38.16M-38.3%71.4%44.2%26.2%
    Sep 2015$61.90MN/A86.1%30.8%19.3%
    Annual, fiscal years ended Sep 2015 to Sep 2024

    Income Statement

    In the fiscal year ended Sep 2024, the net loss widened from the year before. In the quarter ended Jun 2025, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemSep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016Sep 2015
    Revenue$126.08M$132.58M$99.95M$105.14M$94.86M$100.08M$81.34M$73.11M$38.16M$61.90M
    Cost of revenue$33.03M$24.96M$20.34M$17.18M$15.32M$13.64M$14.00M$11.42M$10.91M$8.62M
    Gross profit$93.05M$107.62M$79.61M$87.96M$79.55M$86.44M$67.34M$61.69M$27.25M$53.28M
    Research and development$38.36M$46.59M$50.61M$46.73M$50.19M$53.77M$48.86M$31.82M$18.50M$16.16M
    Operating income-$5.64M$5.15M-$22.10M$6.70M-$1.25M$6.47M-$8.80M$7.10M$16.86M$19.09M
    Net income-$11.54M-$1.54M-$27.27M$4.24M$1.12M$7.59M-$4.46M$3.93M$9.98M$11.95M
    EBITDA$3.11M$13.79M-$12.81M$14.60M$5.29M$13.93M-$1.95M$12.20M$21.76M$22.39M
    Fiscal years ended Sep 2015 to Sep 2024

    Quarterly

    Line itemJun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Revenue$29.57M$28.09M$29.92M$33.23M$30.34M$31.96M$30.55M$27.97M$52.48M$27.20M$24.93M$25.99M
    Gross profit$20.99M$20.25M$22.50M$24.55M$21.89M$24.86M$21.75M$20.93M$45.56M$21.46M$19.67M$20.39M
    Operating income-$5.24M-$4.01M-$2.48M-$613.00K-$5.37M$659.00K-$322.00K-$2.45M$21.41M-$6.58M-$7.23M-$6.61M
    Net income-$5.32M-$5.21M-$3.65M-$3.45M-$7.55M$247.00K-$786.00K$6.69M$7.35M-$7.73M-$7.84M-$14.73M
    Last 12 quarters

    Balance Sheet

    As of Sep 2024, cash and equivalents exceeded long-term debt of $29.55M by $6.56M.

    Annual

    Line itemSep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016Sep 2015
    Total assets$178.56M$185.73M$158.36M$194.59M$168.76M$159.87M$164.13M$136.59M$132.89M$98.71M
    Current assets$81.30M$86.69M$57.59M$70.25M$86.61M$81.42M$81.53M$60.88M$58.56M$67.79M
    Cash and equivalents$36.12M$41.42M$19.00M$31.15M$30.79M$30.36M$23.32M$16.53M$24.99M$55.59M
    Total liabilities$59.66M$65.82M$49.97M$54.51M$37.71M$37.35M$55.52M$25.04M$26.06M$6.84M
    Short-term debtN/AN/A$10.00M$10.00MN/A$3.20M$11.04M$1.75M$925.00K$305.00K
    Long-term debt$29.55M$29.41M$0N/AN/AN/A$0$0$0$0
    Shareholder equity$118.90M$119.91M$108.39M$140.09M$131.06M$122.52M$108.61M$111.56M$106.83M$91.87M
    Fiscal years ended Sep 2015 to Sep 2024

    Quarterly

    Line itemJun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total assets$169.82M$163.21M$163.74M$178.56M$177.41M$182.81M$180.24M$185.73M$188.90M$166.16M$169.75M$158.36M
    Total liabilities$58.51M$52.97M$51.97M$59.66M$59.27M$58.85M$58.09M$65.82M$76.49M$63.61M$62.49M$49.97M
    Cash and equivalents$26.28M$29.18M$30.14M$36.12M$24.30M$33.03M$23.36M$41.42M$44.58M$19.18M$26.43M$19.00M
    Shareholder equity$111.31M$110.25M$111.77M$118.90M$118.14M$123.95M$122.15M$119.91M$112.41M$102.55M$107.26M$108.39M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Sep 2024, capital expenditures exceeded operating cash flow, leaving negative free cash flow.

    Annual

    Line itemSep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018Sep 2017Sep 2016Sep 2015
    Operating cash flow$248.00K$10.51M-$17.22M$15.39M$14.01M$8.04M$34.05M$14.05M$25.17M$15.07M
    Capital expenditures$3.49M$2.92M$3.37M$5.28M$3.67M$6.00M$9.09M$6.43M$8.19M$1.88M
    Free cash flow-$3.24M$7.60M-$20.59M$10.11M$10.34M$2.04M$24.96M$7.62M$16.97M$13.19M
    Dividends paidN/A$918.00KN/A$7.25MN/AN/A$0$0$0$0
    Share repurchasesN/AN/AN/AN/AN/AN/AN/A$4.70MN/A$20.00M
    Investing cash flow-$2.94M-$6.82M$6.23M-$25.24M-$9.07M$9.75M-$23.50M-$16.19M-$55.47M$16.69M
    Financing cash flow-$2.95M$18.41M-$375.00K$10.23M-$4.65M-$11.03M-$3.39M-$6.51M-$199.00K-$19.68M
    Fiscal years ended Sep 2015 to Sep 2024

    Quarterly

    Line itemJun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022
    Operating cash flow$1.41M$949.00K-$7.89M$3.66M-$2.03M$7.42M-$8.79M$1.25M$25.89M-$5.83M-$10.80M
    Capital expenditures$501.00K$319.00K$302.00K$542.00K$959.00K$1.27M$720.00K$748.00K$470.00K$723.00K$977.00K
    Free cash flow$904.00K$630.00K-$8.20M$3.12M-$2.99M$6.14M-$9.51M$502.00K$25.42M-$6.55M-$11.78M
    Last 11 quarters

    Frequently Asked Questions About SRDX

    What is SurModics' annual revenue?

    SurModics reported revenue of $126.08M for the fiscal year ended Sep 30, 2024.

    How fast is SurModics' revenue growing?

    Revenue was down 4.9% for the fiscal year ended Sep 30, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 6.2%.

    Is SurModics profitable?

    No. SurModics reported net income of -$11.54M for the fiscal year ended Sep 30, 2024, with a net margin of -9.2%.

    How much free cash flow does SRDX generate?

    For the fiscal year ended Sep 30, 2024, operating cash flow of $248.00K minus capital expenditures of $3.49M produced free cash flow of -$3.24M.

    How much debt does SurModics have?

    The balance sheet dated Sep 30, 2024 reported long-term debt of $29.55M and cash and equivalents of $36.12M.